// App-Quantinova.ai

e16557 : Fosciclopirox clinical proof of concept in patients with nonmuscle invasive and muscle-invasive bladder cancer.

Researchers

Presenter

  • Scott James Weir

Principal Investigators

  • Janet Baack Kukreja

  • Gerald Steven Falchook

  • Manojkumar Bupathi

  • Rahul Atul Parikh

  • Elizabeth Marie Wulff-Burchfield

  • Robyn Wood

  • Eugene K. Lee

  • Tammy Ham

  • Prasad Dandawate

  • Shrikant Anant

  • Benjamin L. Woolbright

  • Na Zhang

  • Paul Toren

  • Michael Dalton

  • Valentina Zhukova-Harrill

  • Jay Nicholas Umbreit

  • William McCulloch

  • John A. Taylor

Medical Centers

  • University of Kansas Institute for Advancing Medical Innovation, Kansas City, KS

  • University of Colorado Anschutz Medical Campus, Aurora, CO

  • University of Colorado Cancer Center, Aurora, CO

  • Sarah Cannon Research Institute, Denver, CO

  • Univeristy of Texas- MD Anderson Cancer Center, Westerville, OH

  • University of Kansas Medical Center, Westwood, KS

  • University of Kansas Medical Center, Westwood, KS

  • University of Kansas Medical Center, Kansas City, MO

  • University of Kansas Medical Center, Department of Biostatistics, Kansas City, KS

  • CicloMed LLC, Kansas City, MO

  • University of Kansas Health System, Kansas City, KS

  • University of Kansas Medical Center, Department of Biostatistics, Kansas City, KS

  • University of Kansas Medical Center, Department of Biostatistics, Kansas City, KS

  • Clinical Pharmacology Shared Resource, Kansas City, KS

  • Children's Mercy-Kansas City, Kansas City, MO

  • The Gnomon Group, Carrboro, NC

  • Medical School, Cary, NC

  • Catalyst Clinical Research, Wilmington, NC

  • Alba BioPharm Advisors Inc, Raleigh, NC

  • Department of Microbiology, University of Kansas Medical Center, Kansas City, KS

Locations

  • United States

Companies

  • CicloMed LLC

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Bladder Cancer

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Gemcitabine

  • Cisplatin

Outcome

  • N/A

Study Design

  • Pharmacokinetics

Phase

  • NA

Study Id's

  • NCT03348514

  • NCT04608045

  • NCT04525131

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved